Author | Badar M. Mian, MD


Similar outcomes observed with immediate vs delayed radical prostatectomy

August 28, 2020

Survival outcomes are not compromised in men undergoing active surveillance, a recent study finds.

Quality performance initiative may improve TURBT outcomes in bladder cancer

August 14, 2020

Increased usage of bladder diagrams was observed following implementation of the program.

Relugolix emerges as "exciting" new treatment in prostate cancer

July 07, 2020

Dr. Badar M. Mian highlights the safety and efficacy of relugolix, describing the drug as an “exciting new option” for patients with recurrent or advanced prostate cancer.

Is a reduced bacillus Calmette-Guérin regimen feasible?

June 02, 2020

"In the era of BCG shortage, it would have been highly desirable to demonstrate the efficacy and safety of fewer BCG instillations for high-risk bladder cancer. However, reduced frequency of maintenance BCG instillations is associated with increased risk of cancer recurrence, albeit with fewer adverse effects," writes Badar M. Mian, MD.